A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

Donor lymphocyte infusions are used to treat relapse after allogeneic hematopoietic stem cell transplantation, but responses are inadequate. In addition to effector cells, infusions contain CD25(+) regulatory T cells (Treg) that may suppress graft-versus-tumor responses. We undertook a phase I study...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Main Authors: Nikiforow, Sarah, Kim, Haesook T., Daley, Heather, Reynolds, Carol, Jones, Kyle Thomas, Armand, Philippe, Ho, Vincent T., Alyea, Edwin P., Cutler, Corey S., Ritz, Jerome, Antin, Joseph H., Soiffer, Robert J., Koreth, John
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2016
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5046655/
https://ncbi.nlm.nih.gov/pubmed/27354021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.141176
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares